Publications by authors named "Geoffrey Yuen"

Claim this Profile
M
Mass balance, pharmacokinetics, and metabolism of linsitinib in cancer patients.
Srinivasu Poondru, Jorge Chaves, Geoffrey Yuen, Barbara Parker, Elizabeth Conklin

Cancer Chemother Pharmacol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human, open-label dose-escalation and dose-expansion study of the safety, pharmacokinetics, and antitumor effects of an oral ALK inhibitor ASP3026 in patients with advanced solid tumors.
Tianhong Li, Patricia LoRusso, Michael L Maitland, Sai-Hong Ignatius Ou, Erkut Bahceci, Geoffrey Yuen

J Hematol Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abacavir and metabolite pharmacokinetics in HIV-1-infected children and adolescents.
Shane J Cross, John H Rodman, Jane C Lindsey, Brian L Robbins, Charles H Rose, Geoffrey J Yuen

J Acquir Immune Defic Syndr· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steady-state pharmacokinetics of abacavir in plasma and intracellular carbovir triphosphate following administration of abacavir at 600 milligrams once daily and 300 milligrams twice daily in human immunodeficiency virus-infected subjects.
Graeme Moyle, Marta Boffito, Carl Fletcher, Chris Higgs, Phillip E Hay, Geoffrey J Yuen

Antimicrob Agents Chemother· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of the pharmacokinetics of abacavir.
Geoffrey J Yuen, Steve Weller, Gary E Pakes

Clin Pharmacokinet· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men.
Julie B Dumond, Y Sunila Reddy, Luigi Troiani, Jose F Rodriguez, Arlene S Bridges, Geoffrey J Yuen

J Acquir Immune Defic Syndr· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic interaction between fosamprenavir-ritonavir and rifabutin in healthy subjects.
Susan L Ford, Ya-Chi Chen, Yu Lou, Julie Borland, Sherene S Min, Geoffrey J Yuen

Antimicrob Agents Chemother· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of lamivudine in subjects receiving peritoneal dialysis in end-stage renal failure.
Ashwin Asari, Heather Iles-Smith, Ya-Chi Chen, Odin J Naderer, Mark A Johnson, Geoffrey J Yuen

Br J Clin Pharmacol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fosamprenavir plus ritonavir increases plasma ketoconazole and ritonavir exposure, while amprenavir exposure remains unchanged.
Mary B Wire, Charles H Ballow, Julie Borland, Mark J Shelton, Yu Lou, Geoffrey Yuen

Antimicrob Agents Chemother· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coadministration of esomeprazole with fosamprenavir has no impact on steady-state plasma amprenavir pharmacokinetics.
Mark J Shelton, Susan L Ford, Julie Borland, Yu Lou, Mary B Wire, Geoffrey Yuen

J Acquir Immune Defic Syndr· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Equivalent steady-state pharmacokinetics of lamivudine in plasma and lamivudine triphosphate within cells following administration of lamivudine at 300 milligrams once daily and 150 milligrams twice daily.
Geoffrey J Yuen, Yu Lou, Nancy F Bumgarner, Jim P Bishop, Glenn A Smith

Antimicrob Agents Chemother· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily quadruple-drug therapy with adefovir dipivoxil, Lamivudine, Didanosine, and efavirenz in treatment-naive human immunodeficiency virus type 1-infected patients.
Gail Skowron, Daniel R Kuritzkes, Melanie A Thompson, Kathleen E Squires, S Diane Goodwin, Geoffrey J Yuen

J Infect Dis· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis